Penerapan Model Game Based Learning Berbantuan Media Blooket Terhadap Kemampuan Pemahaman Konsep Matematis Peserta Didik Kelas XI Fase F Di SMAN 1 Kecamatan Kapur IX

Restu Nasyatul A, Radhya Yusri, Melisa Melisa


Abstract


Penelitian ini dilatarbelakangi oleh kemampuan pemahaman konsep matematis peserta didik yang masih rendah. Tujuan penelitian ini adalah untuk mengetahui apakah kemampuan pemahaman konsep matematis peserta didik setelah diterapkan model Game Based Learning (GBL) berbantuan media Blooket lebih baik daripada sebelum diterapkan model Game Based Learning (GBL) berbantuan media Blooket pada peserta didik kelas XI Fase F di SMAN 1 Kec. Kapur IX Kab. Lima Puluh Kota. Penelitian ini merupakan penelitian kuantitatif dengan jenis penelitian pre-experimental yang menggunakan desain One Group Pretest–Posttest Design. Populasi penelitian adalah seluruh kelas XI Fase F di SMAN 1 Kec. Kapur IX Kab. Lima Puluh Kota. Pengambilan sampel dilakukan menggunakan teknik purposive sampling, sehingga diperoleh kelas XI F1 sebagai sampel penelitian. Pengumpulan data dilakukan menggunakan instrumen tes uraian (essay) yang diberikan sebelum dan sesudah perlakuan. Data penelitian dianalisis melalui uji normalitas menggunakan uji Lilliefors, kemudian dilanjutkan dengan uji t berpasangan (paired sample t-test) untuk menguji hipotesis. Hasil pengujian hipotesis diperoleh thitung=26,40 dengan ttabel =2,04, pada taraf signifikansi α = 0,05. Karena thitung> ttabel maka H0 ditolak dan H1 diterima. Dengan demikian bisa disimpulkan bahwa pemahaman konsep matematis peserta didik dengan menerapkan model Game Based Learning (GBL) berbantuan media Blooket lebih baik daripada sebelum diterapkan model Game Based Learning (GBL) berbantuan media Blooket

Keywords


Game Based Learning (GBL), Blooket, pemahaman konsep matematis.

Full Text:

PDF

References


Alkaff F, Illavi F, Salamah S, et al. The impact of the Indonesian Chronic Disease Management Program (PROLANIS) on metabolic control and renal function of type 2 diabetes mellitus patients in primary care setting. J Prim Care Community Health. 2021;12:2150132720984409. doi:10.1177/2150132720984409.

Aubert CE, Streit S, da Costa BR, et al. Polypharmacy and specific comorbidities in university primary care settings. Eur J Intern Med. 2016;35:35-42. doi:10.1016/j.ejim.2016.05.022.

Delara M, Murray L, Jafari B, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22:601. doi:10.1186/s12877-022-03279-x.

Febriyanti RM, Irawan AA, Anggriani N, et al. Challenges in implementing Indonesia's community-based chronic disease management program (Prolanis): a scoping review. AIMS Public Health. 2025;12(3):1744-1763. doi:10.3934/publichealth.2025093.

Jerjes W, Majeed A. Polypharmacy as a chronic condition: a diagnostic mindset for safer and smarter care. J Clin Med. 2025;14. doi:10.3390/jcmxxxxxxxx.

Johansson KS, Jimenez-Solem E, Petersen T, et al. Increasing medication use and polypharmacy in type 2 diabetes: the Danish experience from 2000 to 2020. Diabetes Care. 2024;47(7):1184-1192. doi:10

Lisni I, Lestari K, Andalusia LR. Polypharmacy in type 2 diabetes patients of the PROLANIS program in Indonesia: identification of potential drug-drug interaction. Jordan J Pharm Sci. 2025. doi:10.35516/jjps.v18i1.1818.

Matthias A, Fernando G, Somathilake BGK, et al. Predictors and patterns of polypharmacy in chronic diseases in a middle-income country. Int J Physiol Pathophysiol Pharmacol. 2021;13(6):234-242.

Molino CGRC, Chocano-Bedoya P, Sadlon A, et al. Prevalence of polypharmacy in community-dwelling older adults from seven centres in five European countries: a cross-sectional study of DO-HEALTH. BMJ Open. 2022;12. doi:10.1136/bmjopen-2021-051881.

Nasab NF, Rezaeian S, Ezadi S, et al. Prevalence and determinants of polypharmacy: a cross-sectional study among elderly patients with cardiovascular diseases in outpatient clinics. Scientifica (Cairo). 2025;2025 ID. doi:10.1155/2025/xxxxxxxx.

Ngowi J, Munishi C, Ndumwa H, et al. Efforts to address the burden of non-communicable diseases need local evidence and shared lessons from high-burden countries. Ann Glob Health. 2023;89(1):87. doi:10.5334/aogh.4265.

Purnamasari D. The emergence of non-communicable disease in Indonesia. Acta Med Indones. 2018;50(4):273-274.

Rachmawati S, Prihhastuti-Puspitasari H, Zairina E. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review. J Basic Clin Physiol Pharmacol. 2019;30(6). doi:10.1515/jbcpp-2019-0355.

Vitorino LM, Mendes JHL, Santos GS, et al. Prevalence of polypharmacy of older people in a large Brazilian urban center and its associated factors. Int J Environ Res Public Health. 2023;20(10):5903. doi:10.3390/ijerph20105903.

Wang J, Feng Z, Dong Z, et al. Does having a usual primary care provider reduce polypharmacy behaviors of patients with chronic disease? A retrospective study in Hubei Province, China. Front Pharmacol. 2022;12:794863. doi:10.3389/fphar.2021.794863.

Yuliarni I, Komara E, Handayani N. Evaluasi manajemen Program Pengelolaan Penyakit Kronis (Prolanis) dalam meningkatkan kualitas pelayanan BPJS Kesehatan di Puskesmas Singgani Kota Palu. ManBiz J Manag Bus. 2025;4(1):1-12




DOI: https://doi.org/10.30743/best.v9i2.14643

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.